par Tomasi, Lisa;Thiriard, Anaïs 
;Heyndrickx, Leo;Georges, Daphnée ;Van den Wijngaert, Sigi;Olislagers, Véronique ;Sharma, Shilpee ;Matagne, André;Ackerman, Margaret M.E.;Ariën, Kevin K;Goetghebuer, Tessa ;Marchant, Arnaud
Référence Open Forum Infectious Diseases, 9, 11, page (ofac554)
Publication Publié, 2022-11-01
;Heyndrickx, Leo;Georges, Daphnée ;Van den Wijngaert, Sigi;Olislagers, Véronique ;Sharma, Shilpee ;Matagne, André;Ackerman, Margaret M.E.;Ariën, Kevin K;Goetghebuer, Tessa ;Marchant, Arnaud Référence Open Forum Infectious Diseases, 9, 11, page (ofac554)
Publication Publié, 2022-11-01
Article révisé par les pairs
| Résumé : | The basis of the less severe clinical presentation of coronavirus disease 2019 (COVID-19) in children as compared with adults remains incompletely understood. Studies have suggested that a more potent boosting of immunity to endemic common cold coronaviruses (HCoVs) may protect children. |
